Adagio Medical Secures CE Mark For VCLAS Catheter, Launches ULTC System In Europe, Presents CRYOCURE-VT Data, Gains FDA Approval For FULCRUM-VT Study, And Completes Nasdaq Listing Following Business Combination
Adagio Medical Secures CE Mark For VCLAS Catheter, Launches ULTC System In Europe, Presents CRYOCURE-VT Data, Gains FDA Approval For FULCRUM-VT Study, And Completes Nasdaq Listing Following Business Combination
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.